Significant heterogeneity in long-term risks of cirrhosis or hepatocellular carcinoma among a national cohort of US veterans with non-cirrhotic, treatment naive chronic hepatitis B in the immune tolerant phase

被引：0
|
作者：
Yang, Zeyuan [1 ]
Cheung, Ramsey C. [2 ]
Wong, Robert [2 ]
机构：
[1] VA Palo Alto Hlth Care Syst, Palo Alto, CA USA
[2] VA Palo Alto Healthcare Syst, Stanford Univ Sch Med, Palo Alto, CA USA
来源：
JOURNAL OF HEPATOLOGY | 2023年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
WED-180
引用
收藏
页码：S1107 / S1107
页数：1
相关论文
共 20 条
  • [1] On-treatment risks of cirrhosis and hepatocellular carcinoma among a large cohort of predominantly non- Asian patients with non-cirrhotic chronic hepatitis B
    Yang, Zeyuan
    Cheung, Ramsey C.
    Chitnis, Amit S.
    Zhang, Wei
    Gish, Robert G.
    Wong, Robert J.
    JHEP REPORTS, 2023, 5 (10)
  • [2] Long-Term Risks of Cirrhosis and Hepatocellular Carcinoma Among Treatment Naive Chronic Hepatitis B Patients by Baseline Hepatitis B Viral Load
    Yang, Zeyuan
    Cheung, Ramsey
    Jou, Janice
    Lim, Joseph
    Wong, Robert
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S) : S1401 - S1402
  • [3] Significant disparities in risk of cirrhosis and hepatocellular carcinoma among non-cirrhotic, treatment naive, e-antigen negative hepatitis B patients with low levels of serum alanine aminotransferase
    Yang, Zeyuan
    Cheung, Ramsey C.
    Wong, Robert
    JOURNAL OF HEPATOLOGY, 2023, 78 : S1084 - S1085
  • [4] ASSOCIATION OF ASPIRIN AND STATIN USE WITH HEPATOCELLULAR CARCINOMA RISK IN TREATMENT-NAIVE NON-CIRRHOTIC PATIENTS WITH CHRONIC HEPATITIS B
    Choi, Won-Mook
    Kim, Hyo Jeong
    Ko, Min Jung
    Lim, Young-Suk
    HEPATOLOGY, 2020, 72 : 100A - 100A
  • [5] RACE/ETHNICITY-SPECIFIC DIFFERENCES IN ON-TREATMENT RISK OF CIRRHOSIS AMONG A NATIONAL COHORT OF NON-CIRRHOTIC PATIENTS WITH CHRONIC HEPATITIS B
    Yang, Zeyuan
    Cheung, Ramsey
    Wong, Robert
    GASTROENTEROLOGY, 2023, 164 (06) : S1362 - S1363
  • [6] Hepatocellular carcinoma after treatment cessation in non-cirrhotic HBeAg-negative chronic hepatitis B: A multicentre cohort study
    Papatheodoridi, Margarita
    Su, Tung-Hung
    Hadziyannis, Emilia
    Liao, Chun-Hsun
    Orfanidou, Afroditi
    Yang, Hung-Chi
    Zachou, Kalliopi
    Liu, Chun-Jen
    Kourikou, Anastasia
    Gatselis, Nikolaos
    Manolakopoulos, Spilios
    Dalekos, George
    Kao, Jia-Horng
    Hadziyannis, Stephanos
    Papatheodoridis, George, V
    LIVER INTERNATIONAL, 2022, 42 (03) : 541 - 550
  • [7] Incidence of Hepatocellular Carcinoma (HCC) in non-cirrhotic chronic hepatitis B (CHB) patients with low ALT levels in a multicenter US Cohort
    Hoang, Joseph K.
    Nguyen, Nghia H.
    Lin, Derek
    Vu, Vinh D.
    Trinh, Huy N.
    Li, Jiayi
    Zhang, Jian Q.
    Nguyen, Huy A.
    Nguyen, Khanh
    Nguyen, Mindie H.
    HEPATOLOGY, 2014, 60 : 1088A - 1088A
  • [8] Incidence and Risk Factors in the Development of Hepatocellular Carcinoma (HCC) in Non-Cirrhotic and Cirrhotic Patients with Chronic Hepatitis B (CHB): Results of a Multicenter US Cohort Study
    Sonu, Irene S.
    Nguyen, Long H.
    Chen, Christy
    Kin, Kevin C.
    Ha, Nghiem B.
    Trinh, Huy N.
    Ahmed, Aijaz
    Li, Jiayi
    Zhang, Jian Q.
    Nguyen, Mindie H.
    HEPATOLOGY, 2012, 56 : 478A - 479A
  • [9] Non-linear association between serum hepatitis B virus DNA levels and hepatocellular carcinoma risk in treatment-naive, non-cirrhotic chronic hepatitis B patients
    Kim, G. -A.
    Han, S.
    Choi, G. H.
    Choi, J.
    Lim, Y. -S.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S474 - S474
  • [10] Development of hepatocellular carcinoma in a non-cirrhotic, long-term responder to antiviral therapy, chronic hepatitis C patient: what kind of surveillance?
    Bertolini, Elena
    Bassi, Fabio
    Fornaciari, Giovanni
    ANNALS OF GASTROENTEROLOGY, 2013, 26 (01): : 80 - 83
12